Secukinumab Market, Global Outlook and Forecast 2022-2028
Secukinumab is a fully humanized monoclonal anti-IL-17A antibody and the first in its class to be approved by the US Food and Drug Administration for the treatment of moderate to severe plaque psoriasis.
This report contains market size and forecasts of Secukinumab in global, including the following market information:
Global Secukinumab Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Secukinumab Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Secukinumab companies in 2021 (%)
The global Secukinumab market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Patent Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Secukinumab include Carbosynth, TargetMol Chemicals, Changzhou Chenhong Biotechnology, DC Chemicals, Huatesheng Biotechnology, Hubei Guangao Biotechnology, Hubei Kele Fine Chemical, Hubei Widely Chemical Technology and Hubei Xingcheng Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Secukinumab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Secukinumab Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Secukinumab Market Segment Percentages, by Type, 2021 (%)
Global Secukinumab Market Segment Percentages, by Application, 2021 (%)
Global Secukinumab Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Secukinumab revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Secukinumab revenues share in global market, 2021 (%)
Key companies Secukinumab sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Secukinumab sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Secukinumab in global, including the following market information:
Global Secukinumab Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Secukinumab Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Secukinumab companies in 2021 (%)
The global Secukinumab market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Patent Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Secukinumab include Carbosynth, TargetMol Chemicals, Changzhou Chenhong Biotechnology, DC Chemicals, Huatesheng Biotechnology, Hubei Guangao Biotechnology, Hubei Kele Fine Chemical, Hubei Widely Chemical Technology and Hubei Xingcheng Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Secukinumab manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Secukinumab Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Secukinumab Market Segment Percentages, by Type, 2021 (%)
- Patent
- Generic
Global Secukinumab Market Segment Percentages, by Application, 2021 (%)
- Chemical
- Pharmaceutical
Global Secukinumab Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Secukinumab revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Secukinumab revenues share in global market, 2021 (%)
Key companies Secukinumab sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Secukinumab sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Carbosynth
- TargetMol Chemicals
- Changzhou Chenhong Biotechnology
- DC Chemicals
- Huatesheng Biotechnology
- Hubei Guangao Biotechnology
- Hubei Kele Fine Chemical
- Hubei Widely Chemical Technology
- Hubei Xingcheng Biotechnology
- Hubei Zhongshan Medical Technology
- Jiangxi Ruiweier Biotechnology
- Nantong Hi-Future Biotechnology
- Shanghai Biochempartner
- Shanghai Minkai Biotechnology
- Shanghai Yifei Biotechnology
- Shanghai Yu'ang Chemical
- Sichuan Weiqi Biotechnology
- Taizhou KEDE Chemical
- WeiShi Reagent
- Wuhan Dingxintong Pharmaceutical
- Wuhan Fortuna Chemical
- Wuhan Topule Biopharmaceutical
- Wuhan Weisman Bioengineering
- Wuhan Yingnuo Pharmaceutical Technology
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Secukinumab Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Secukinumab Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL SECUKINUMAB OVERALL MARKET SIZE
2.1 Global Secukinumab Market Size: 2021 VS 2028
2.2 Global Secukinumab Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Secukinumab Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Secukinumab Players in Global Market
3.2 Top Global Secukinumab Companies Ranked by Revenue
3.3 Global Secukinumab Revenue by Companies
3.4 Global Secukinumab Sales by Companies
3.5 Global Secukinumab Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Secukinumab Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Secukinumab Product Type
3.8 Tier 1, Tier 2 and Tier 3 Secukinumab Players in Global Market
3.8.1 List of Global Tier 1 Secukinumab Companies
3.8.2 List of Global Tier 2 and Tier 3 Secukinumab Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Secukinumab Market Size Markets, 2021 & 2028
4.1.2 Patent
4.1.3 Generic
4.2 By Type - Global Secukinumab Revenue & Forecasts
4.2.1 By Type - Global Secukinumab Revenue, 2017-2022
4.2.2 By Type - Global Secukinumab Revenue, 2023-2028
4.2.3 By Type - Global Secukinumab Revenue Market Share, 2017-2028
4.3 By Type - Global Secukinumab Sales & Forecasts
4.3.1 By Type - Global Secukinumab Sales, 2017-2022
4.3.2 By Type - Global Secukinumab Sales, 2023-2028
4.3.3 By Type - Global Secukinumab Sales Market Share, 2017-2028
4.4 By Type - Global Secukinumab Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Secukinumab Market Size, 2021 & 2028
5.1.2 Chemical
5.1.3 Pharmaceutical
5.2 By Application - Global Secukinumab Revenue & Forecasts
5.2.1 By Application - Global Secukinumab Revenue, 2017-2022
5.2.2 By Application - Global Secukinumab Revenue, 2023-2028
5.2.3 By Application - Global Secukinumab Revenue Market Share, 2017-2028
5.3 By Application - Global Secukinumab Sales & Forecasts
5.3.1 By Application - Global Secukinumab Sales, 2017-2022
5.3.2 By Application - Global Secukinumab Sales, 2023-2028
5.3.3 By Application - Global Secukinumab Sales Market Share, 2017-2028
5.4 By Application - Global Secukinumab Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Secukinumab Market Size, 2021 & 2028
6.2 By Region - Global Secukinumab Revenue & Forecasts
6.2.1 By Region - Global Secukinumab Revenue, 2017-2022
6.2.2 By Region - Global Secukinumab Revenue, 2023-2028
6.2.3 By Region - Global Secukinumab Revenue Market Share, 2017-2028
6.3 By Region - Global Secukinumab Sales & Forecasts
6.3.1 By Region - Global Secukinumab Sales, 2017-2022
6.3.2 By Region - Global Secukinumab Sales, 2023-2028
6.3.3 By Region - Global Secukinumab Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Secukinumab Revenue, 2017-2028
6.4.2 By Country - North America Secukinumab Sales, 2017-2028
6.4.3 US Secukinumab Market Size, 2017-2028
6.4.4 Canada Secukinumab Market Size, 2017-2028
6.4.5 Mexico Secukinumab Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Secukinumab Revenue, 2017-2028
6.5.2 By Country - Europe Secukinumab Sales, 2017-2028
6.5.3 Germany Secukinumab Market Size, 2017-2028
6.5.4 France Secukinumab Market Size, 2017-2028
6.5.5 U.K. Secukinumab Market Size, 2017-2028
6.5.6 Italy Secukinumab Market Size, 2017-2028
6.5.7 Russia Secukinumab Market Size, 2017-2028
6.5.8 Nordic Countries Secukinumab Market Size, 2017-2028
6.5.9 Benelux Secukinumab Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Secukinumab Revenue, 2017-2028
6.6.2 By Region - Asia Secukinumab Sales, 2017-2028
6.6.3 China Secukinumab Market Size, 2017-2028
6.6.4 Japan Secukinumab Market Size, 2017-2028
6.6.5 South Korea Secukinumab Market Size, 2017-2028
6.6.6 Southeast Asia Secukinumab Market Size, 2017-2028
6.6.7 India Secukinumab Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Secukinumab Revenue, 2017-2028
6.7.2 By Country - South America Secukinumab Sales, 2017-2028
6.7.3 Brazil Secukinumab Market Size, 2017-2028
6.7.4 Argentina Secukinumab Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Secukinumab Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Secukinumab Sales, 2017-2028
6.8.3 Turkey Secukinumab Market Size, 2017-2028
6.8.4 Israel Secukinumab Market Size, 2017-2028
6.8.5 Saudi Arabia Secukinumab Market Size, 2017-2028
6.8.6 UAE Secukinumab Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Carbosynth
7.1.1 Carbosynth Corporate Summary
7.1.2 Carbosynth Business Overview
7.1.3 Carbosynth Secukinumab Major Product Offerings
7.1.4 Carbosynth Secukinumab Sales and Revenue in Global (2017-2022)
7.1.5 Carbosynth Key News
7.2 TargetMol Chemicals
7.2.1 TargetMol Chemicals Corporate Summary
7.2.2 TargetMol Chemicals Business Overview
7.2.3 TargetMol Chemicals Secukinumab Major Product Offerings
7.2.4 TargetMol Chemicals Secukinumab Sales and Revenue in Global (2017-2022)
7.2.5 TargetMol Chemicals Key News
7.3 Changzhou Chenhong Biotechnology
7.3.1 Changzhou Chenhong Biotechnology Corporate Summary
7.3.2 Changzhou Chenhong Biotechnology Business Overview
7.3.3 Changzhou Chenhong Biotechnology Secukinumab Major Product Offerings
7.3.4 Changzhou Chenhong Biotechnology Secukinumab Sales and Revenue in Global (2017-2022)
7.3.5 Changzhou Chenhong Biotechnology Key News
7.4 DC Chemicals
7.4.1 DC Chemicals Corporate Summary
7.4.2 DC Chemicals Business Overview
7.4.3 DC Chemicals Secukinumab Major Product Offerings
7.4.4 DC Chemicals Secukinumab Sales and Revenue in Global (2017-2022)
7.4.5 DC Chemicals Key News
7.5 Huatesheng Biotechnology
7.5.1 Huatesheng Biotechnology Corporate Summary
7.5.2 Huatesheng Biotechnology Business Overview
7.5.3 Huatesheng Biotechnology Secukinumab Major Product Offerings
7.5.4 Huatesheng Biotechnology Secukinumab Sales and Revenue in Global (2017-2022)
7.5.5 Huatesheng Biotechnology Key News
7.6 Hubei Guangao Biotechnology
7.6.1 Hubei Guangao Biotechnology Corporate Summary
7.6.2 Hubei Guangao Biotechnology Business Overview
7.6.3 Hubei Guangao Biotechnology Secukinumab Major Product Offerings
7.6.4 Hubei Guangao Biotechnology Secukinumab Sales and Revenue in Global (2017-2022)
7.6.5 Hubei Guangao Biotechnology Key News
7.7 Hubei Kele Fine Chemical
7.7.1 Hubei Kele Fine Chemical Corporate Summary
7.7.2 Hubei Kele Fine Chemical Business Overview
7.7.3 Hubei Kele Fine Chemical Secukinumab Major Product Offerings
7.7.4 Hubei Kele Fine Chemical Secukinumab Sales and Revenue in Global (2017-2022)
7.7.5 Hubei Kele Fine Chemical Key News
7.8 Hubei Widely Chemical Technology
7.8.1 Hubei Widely Chemical Technology Corporate Summary
7.8.2 Hubei Widely Chemical Technology Business Overview
7.8.3 Hubei Widely Chemical Technology Secukinumab Major Product Offerings
7.8.4 Hubei Widely Chemical Technology Secukinumab Sales and Revenue in Global (2017-2022)
7.8.5 Hubei Widely Chemical Technology Key News
7.9 Hubei Xingcheng Biotechnology
7.9.1 Hubei Xingcheng Biotechnology Corporate Summary
7.9.2 Hubei Xingcheng Biotechnology Business Overview
7.9.3 Hubei Xingcheng Biotechnology Secukinumab Major Product Offerings
7.9.4 Hubei Xingcheng Biotechnology Secukinumab Sales and Revenue in Global (2017-2022)
7.9.5 Hubei Xingcheng Biotechnology Key News
7.10 Hubei Zhongshan Medical Technology
7.10.1 Hubei Zhongshan Medical Technology Corporate Summary
7.10.2 Hubei Zhongshan Medical Technology Business Overview
7.10.3 Hubei Zhongshan Medical Technology Secukinumab Major Product Offerings
7.10.4 Hubei Zhongshan Medical Technology Secukinumab Sales and Revenue in Global (2017-2022)
7.10.5 Hubei Zhongshan Medical Technology Key News
7.11 Jiangxi Ruiweier Biotechnology
7.11.1 Jiangxi Ruiweier Biotechnology Corporate Summary
7.11.2 Jiangxi Ruiweier Biotechnology Secukinumab Business Overview
7.11.3 Jiangxi Ruiweier Biotechnology Secukinumab Major Product Offerings
7.11.4 Jiangxi Ruiweier Biotechnology Secukinumab Sales and Revenue in Global (2017-2022)
7.11.5 Jiangxi Ruiweier Biotechnology Key News
7.12 Nantong Hi-Future Biotechnology
7.12.1 Nantong Hi-Future Biotechnology Corporate Summary
7.12.2 Nantong Hi-Future Biotechnology Secukinumab Business Overview
7.12.3 Nantong Hi-Future Biotechnology Secukinumab Major Product Offerings
7.12.4 Nantong Hi-Future Biotechnology Secukinumab Sales and Revenue in Global (2017-2022)
7.12.5 Nantong Hi-Future Biotechnology Key News
7.13 Shanghai Biochempartner
7.13.1 Shanghai Biochempartner Corporate Summary
7.13.2 Shanghai Biochempartner Secukinumab Business Overview
7.13.3 Shanghai Biochempartner Secukinumab Major Product Offerings
7.13.4 Shanghai Biochempartner Secukinumab Sales and Revenue in Global (2017-2022)
7.13.5 Shanghai Biochempartner Key News
7.14 Shanghai Minkai Biotechnology
7.14.1 Shanghai Minkai Biotechnology Corporate Summary
7.14.2 Shanghai Minkai Biotechnology Business Overview
7.14.3 Shanghai Minkai Biotechnology Secukinumab Major Product Offerings
7.14.4 Shanghai Minkai Biotechnology Secukinumab Sales and Revenue in Global (2017-2022)
7.14.5 Shanghai Minkai Biotechnology Key News
7.15 Shanghai Yifei Biotechnology
7.15.1 Shanghai Yifei Biotechnology Corporate Summary
7.15.2 Shanghai Yifei Biotechnology Business Overview
7.15.3 Shanghai Yifei Biotechnology Secukinumab Major Product Offerings
7.15.4 Shanghai Yifei Biotechnology Secukinumab Sales and Revenue in Global (2017-2022)
7.15.5 Shanghai Yifei Biotechnology Key News
7.16 Shanghai Yu'ang Chemical
7.16.1 Shanghai Yu'ang Chemical Corporate Summary
7.16.2 Shanghai Yu'ang Chemical Business Overview
7.16.3 Shanghai Yu'ang Chemical Secukinumab Major Product Offerings
7.16.4 Shanghai Yu'ang Chemical Secukinumab Sales and Revenue in Global (2017-2022)
7.16.5 Shanghai Yu'ang Chemical Key News
7.17 Sichuan Weiqi Biotechnology
7.17.1 Sichuan Weiqi Biotechnology Corporate Summary
7.17.2 Sichuan Weiqi Biotechnology Business Overview
7.17.3 Sichuan Weiqi Biotechnology Secukinumab Major Product Offerings
7.17.4 Sichuan Weiqi Biotechnology Secukinumab Sales and Revenue in Global (2017-2022)
7.17.5 Sichuan Weiqi Biotechnology Key News
7.18 Taizhou KEDE Chemical
7.18.1 Taizhou KEDE Chemical Corporate Summary
7.18.2 Taizhou KEDE Chemical Business Overview
7.18.3 Taizhou KEDE Chemical Secukinumab Major Product Offerings
7.18.4 Taizhou KEDE Chemical Secukinumab Sales and Revenue in Global (2017-2022)
7.18.5 Taizhou KEDE Chemical Key News
7.19 WeiShi Reagent
7.19.1 WeiShi Reagent Corporate Summary
7.19.2 WeiShi Reagent Business Overview
7.19.3 WeiShi Reagent Secukinumab Major Product Offerings
7.19.4 WeiShi Reagent Secukinumab Sales and Revenue in Global (2017-2022)
7.19.5 WeiShi Reagent Key News
7.20 Wuhan Dingxintong Pharmaceutical
7.20.1 Wuhan Dingxintong Pharmaceutical Corporate Summary
7.20.2 Wuhan Dingxintong Pharmaceutical Business Overview
7.20.3 Wuhan Dingxintong Pharmaceutical Secukinumab Major Product Offerings
7.20.4 Wuhan Dingxintong Pharmaceutical Secukinumab Sales and Revenue in Global (2017-2022)
7.20.5 Wuhan Dingxintong Pharmaceutical Key News
7.21 Wuhan Fortuna Chemical
7.21.1 Wuhan Fortuna Chemical Corporate Summary
7.21.2 Wuhan Fortuna Chemical Business Overview
7.21.3 Wuhan Fortuna Chemical Secukinumab Major Product Offerings
7.21.4 Wuhan Fortuna Chemical Secukinumab Sales and Revenue in Global (2017-2022)
7.21.5 Wuhan Fortuna Chemical Key News
7.22 Wuhan Topule Biopharmaceutical
7.22.1 Wuhan Topule Biopharmaceutical Corporate Summary
7.22.2 Wuhan Topule Biopharmaceutical Business Overview
7.22.3 Wuhan Topule Biopharmaceutical Secukinumab Major Product Offerings
7.22.4 Wuhan Topule Biopharmaceutical Secukinumab Sales and Revenue in Global (2017-2022)
7.22.5 Wuhan Topule Biopharmaceutical Key News
7.23 Wuhan Weisman Bioengineering
7.23.1 Wuhan Weisman Bioengineering Corporate Summary
7.23.2 Wuhan Weisman Bioengineering Business Overview
7.23.3 Wuhan Weisman Bioengineering Secukinumab Major Product Offerings
7.23.4 Wuhan Weisman Bioengineering Secukinumab Sales and Revenue in Global (2017-2022)
7.23.5 Wuhan Weisman Bioengineering Key News
7.24 Wuhan Yingnuo Pharmaceutical Technology
7.24.1 Wuhan Yingnuo Pharmaceutical Technology Corporate Summary
7.24.2 Wuhan Yingnuo Pharmaceutical Technology Business Overview
7.24.3 Wuhan Yingnuo Pharmaceutical Technology Secukinumab Major Product Offerings
7.24.4 Wuhan Yingnuo Pharmaceutical Technology Secukinumab Sales and Revenue in Global (2017-2022)
7.24.5 Wuhan Yingnuo Pharmaceutical Technology Key News
8 GLOBAL SECUKINUMAB PRODUCTION CAPACITY, ANALYSIS
8.1 Global Secukinumab Production Capacity, 2017-2028
8.2 Secukinumab Production Capacity of Key Manufacturers in Global Market
8.3 Global Secukinumab Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 SECUKINUMAB SUPPLY CHAIN ANALYSIS
10.1 Secukinumab Industry Value Chain
10.2 Secukinumab Upstream Market
10.3 Secukinumab Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Secukinumab Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Secukinumab Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Secukinumab Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL SECUKINUMAB OVERALL MARKET SIZE
2.1 Global Secukinumab Market Size: 2021 VS 2028
2.2 Global Secukinumab Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Secukinumab Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Secukinumab Players in Global Market
3.2 Top Global Secukinumab Companies Ranked by Revenue
3.3 Global Secukinumab Revenue by Companies
3.4 Global Secukinumab Sales by Companies
3.5 Global Secukinumab Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Secukinumab Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Secukinumab Product Type
3.8 Tier 1, Tier 2 and Tier 3 Secukinumab Players in Global Market
3.8.1 List of Global Tier 1 Secukinumab Companies
3.8.2 List of Global Tier 2 and Tier 3 Secukinumab Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Secukinumab Market Size Markets, 2021 & 2028
4.1.2 Patent
4.1.3 Generic
4.2 By Type - Global Secukinumab Revenue & Forecasts
4.2.1 By Type - Global Secukinumab Revenue, 2017-2022
4.2.2 By Type - Global Secukinumab Revenue, 2023-2028
4.2.3 By Type - Global Secukinumab Revenue Market Share, 2017-2028
4.3 By Type - Global Secukinumab Sales & Forecasts
4.3.1 By Type - Global Secukinumab Sales, 2017-2022
4.3.2 By Type - Global Secukinumab Sales, 2023-2028
4.3.3 By Type - Global Secukinumab Sales Market Share, 2017-2028
4.4 By Type - Global Secukinumab Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Secukinumab Market Size, 2021 & 2028
5.1.2 Chemical
5.1.3 Pharmaceutical
5.2 By Application - Global Secukinumab Revenue & Forecasts
5.2.1 By Application - Global Secukinumab Revenue, 2017-2022
5.2.2 By Application - Global Secukinumab Revenue, 2023-2028
5.2.3 By Application - Global Secukinumab Revenue Market Share, 2017-2028
5.3 By Application - Global Secukinumab Sales & Forecasts
5.3.1 By Application - Global Secukinumab Sales, 2017-2022
5.3.2 By Application - Global Secukinumab Sales, 2023-2028
5.3.3 By Application - Global Secukinumab Sales Market Share, 2017-2028
5.4 By Application - Global Secukinumab Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Secukinumab Market Size, 2021 & 2028
6.2 By Region - Global Secukinumab Revenue & Forecasts
6.2.1 By Region - Global Secukinumab Revenue, 2017-2022
6.2.2 By Region - Global Secukinumab Revenue, 2023-2028
6.2.3 By Region - Global Secukinumab Revenue Market Share, 2017-2028
6.3 By Region - Global Secukinumab Sales & Forecasts
6.3.1 By Region - Global Secukinumab Sales, 2017-2022
6.3.2 By Region - Global Secukinumab Sales, 2023-2028
6.3.3 By Region - Global Secukinumab Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Secukinumab Revenue, 2017-2028
6.4.2 By Country - North America Secukinumab Sales, 2017-2028
6.4.3 US Secukinumab Market Size, 2017-2028
6.4.4 Canada Secukinumab Market Size, 2017-2028
6.4.5 Mexico Secukinumab Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Secukinumab Revenue, 2017-2028
6.5.2 By Country - Europe Secukinumab Sales, 2017-2028
6.5.3 Germany Secukinumab Market Size, 2017-2028
6.5.4 France Secukinumab Market Size, 2017-2028
6.5.5 U.K. Secukinumab Market Size, 2017-2028
6.5.6 Italy Secukinumab Market Size, 2017-2028
6.5.7 Russia Secukinumab Market Size, 2017-2028
6.5.8 Nordic Countries Secukinumab Market Size, 2017-2028
6.5.9 Benelux Secukinumab Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Secukinumab Revenue, 2017-2028
6.6.2 By Region - Asia Secukinumab Sales, 2017-2028
6.6.3 China Secukinumab Market Size, 2017-2028
6.6.4 Japan Secukinumab Market Size, 2017-2028
6.6.5 South Korea Secukinumab Market Size, 2017-2028
6.6.6 Southeast Asia Secukinumab Market Size, 2017-2028
6.6.7 India Secukinumab Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Secukinumab Revenue, 2017-2028
6.7.2 By Country - South America Secukinumab Sales, 2017-2028
6.7.3 Brazil Secukinumab Market Size, 2017-2028
6.7.4 Argentina Secukinumab Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Secukinumab Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Secukinumab Sales, 2017-2028
6.8.3 Turkey Secukinumab Market Size, 2017-2028
6.8.4 Israel Secukinumab Market Size, 2017-2028
6.8.5 Saudi Arabia Secukinumab Market Size, 2017-2028
6.8.6 UAE Secukinumab Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Carbosynth
7.1.1 Carbosynth Corporate Summary
7.1.2 Carbosynth Business Overview
7.1.3 Carbosynth Secukinumab Major Product Offerings
7.1.4 Carbosynth Secukinumab Sales and Revenue in Global (2017-2022)
7.1.5 Carbosynth Key News
7.2 TargetMol Chemicals
7.2.1 TargetMol Chemicals Corporate Summary
7.2.2 TargetMol Chemicals Business Overview
7.2.3 TargetMol Chemicals Secukinumab Major Product Offerings
7.2.4 TargetMol Chemicals Secukinumab Sales and Revenue in Global (2017-2022)
7.2.5 TargetMol Chemicals Key News
7.3 Changzhou Chenhong Biotechnology
7.3.1 Changzhou Chenhong Biotechnology Corporate Summary
7.3.2 Changzhou Chenhong Biotechnology Business Overview
7.3.3 Changzhou Chenhong Biotechnology Secukinumab Major Product Offerings
7.3.4 Changzhou Chenhong Biotechnology Secukinumab Sales and Revenue in Global (2017-2022)
7.3.5 Changzhou Chenhong Biotechnology Key News
7.4 DC Chemicals
7.4.1 DC Chemicals Corporate Summary
7.4.2 DC Chemicals Business Overview
7.4.3 DC Chemicals Secukinumab Major Product Offerings
7.4.4 DC Chemicals Secukinumab Sales and Revenue in Global (2017-2022)
7.4.5 DC Chemicals Key News
7.5 Huatesheng Biotechnology
7.5.1 Huatesheng Biotechnology Corporate Summary
7.5.2 Huatesheng Biotechnology Business Overview
7.5.3 Huatesheng Biotechnology Secukinumab Major Product Offerings
7.5.4 Huatesheng Biotechnology Secukinumab Sales and Revenue in Global (2017-2022)
7.5.5 Huatesheng Biotechnology Key News
7.6 Hubei Guangao Biotechnology
7.6.1 Hubei Guangao Biotechnology Corporate Summary
7.6.2 Hubei Guangao Biotechnology Business Overview
7.6.3 Hubei Guangao Biotechnology Secukinumab Major Product Offerings
7.6.4 Hubei Guangao Biotechnology Secukinumab Sales and Revenue in Global (2017-2022)
7.6.5 Hubei Guangao Biotechnology Key News
7.7 Hubei Kele Fine Chemical
7.7.1 Hubei Kele Fine Chemical Corporate Summary
7.7.2 Hubei Kele Fine Chemical Business Overview
7.7.3 Hubei Kele Fine Chemical Secukinumab Major Product Offerings
7.7.4 Hubei Kele Fine Chemical Secukinumab Sales and Revenue in Global (2017-2022)
7.7.5 Hubei Kele Fine Chemical Key News
7.8 Hubei Widely Chemical Technology
7.8.1 Hubei Widely Chemical Technology Corporate Summary
7.8.2 Hubei Widely Chemical Technology Business Overview
7.8.3 Hubei Widely Chemical Technology Secukinumab Major Product Offerings
7.8.4 Hubei Widely Chemical Technology Secukinumab Sales and Revenue in Global (2017-2022)
7.8.5 Hubei Widely Chemical Technology Key News
7.9 Hubei Xingcheng Biotechnology
7.9.1 Hubei Xingcheng Biotechnology Corporate Summary
7.9.2 Hubei Xingcheng Biotechnology Business Overview
7.9.3 Hubei Xingcheng Biotechnology Secukinumab Major Product Offerings
7.9.4 Hubei Xingcheng Biotechnology Secukinumab Sales and Revenue in Global (2017-2022)
7.9.5 Hubei Xingcheng Biotechnology Key News
7.10 Hubei Zhongshan Medical Technology
7.10.1 Hubei Zhongshan Medical Technology Corporate Summary
7.10.2 Hubei Zhongshan Medical Technology Business Overview
7.10.3 Hubei Zhongshan Medical Technology Secukinumab Major Product Offerings
7.10.4 Hubei Zhongshan Medical Technology Secukinumab Sales and Revenue in Global (2017-2022)
7.10.5 Hubei Zhongshan Medical Technology Key News
7.11 Jiangxi Ruiweier Biotechnology
7.11.1 Jiangxi Ruiweier Biotechnology Corporate Summary
7.11.2 Jiangxi Ruiweier Biotechnology Secukinumab Business Overview
7.11.3 Jiangxi Ruiweier Biotechnology Secukinumab Major Product Offerings
7.11.4 Jiangxi Ruiweier Biotechnology Secukinumab Sales and Revenue in Global (2017-2022)
7.11.5 Jiangxi Ruiweier Biotechnology Key News
7.12 Nantong Hi-Future Biotechnology
7.12.1 Nantong Hi-Future Biotechnology Corporate Summary
7.12.2 Nantong Hi-Future Biotechnology Secukinumab Business Overview
7.12.3 Nantong Hi-Future Biotechnology Secukinumab Major Product Offerings
7.12.4 Nantong Hi-Future Biotechnology Secukinumab Sales and Revenue in Global (2017-2022)
7.12.5 Nantong Hi-Future Biotechnology Key News
7.13 Shanghai Biochempartner
7.13.1 Shanghai Biochempartner Corporate Summary
7.13.2 Shanghai Biochempartner Secukinumab Business Overview
7.13.3 Shanghai Biochempartner Secukinumab Major Product Offerings
7.13.4 Shanghai Biochempartner Secukinumab Sales and Revenue in Global (2017-2022)
7.13.5 Shanghai Biochempartner Key News
7.14 Shanghai Minkai Biotechnology
7.14.1 Shanghai Minkai Biotechnology Corporate Summary
7.14.2 Shanghai Minkai Biotechnology Business Overview
7.14.3 Shanghai Minkai Biotechnology Secukinumab Major Product Offerings
7.14.4 Shanghai Minkai Biotechnology Secukinumab Sales and Revenue in Global (2017-2022)
7.14.5 Shanghai Minkai Biotechnology Key News
7.15 Shanghai Yifei Biotechnology
7.15.1 Shanghai Yifei Biotechnology Corporate Summary
7.15.2 Shanghai Yifei Biotechnology Business Overview
7.15.3 Shanghai Yifei Biotechnology Secukinumab Major Product Offerings
7.15.4 Shanghai Yifei Biotechnology Secukinumab Sales and Revenue in Global (2017-2022)
7.15.5 Shanghai Yifei Biotechnology Key News
7.16 Shanghai Yu'ang Chemical
7.16.1 Shanghai Yu'ang Chemical Corporate Summary
7.16.2 Shanghai Yu'ang Chemical Business Overview
7.16.3 Shanghai Yu'ang Chemical Secukinumab Major Product Offerings
7.16.4 Shanghai Yu'ang Chemical Secukinumab Sales and Revenue in Global (2017-2022)
7.16.5 Shanghai Yu'ang Chemical Key News
7.17 Sichuan Weiqi Biotechnology
7.17.1 Sichuan Weiqi Biotechnology Corporate Summary
7.17.2 Sichuan Weiqi Biotechnology Business Overview
7.17.3 Sichuan Weiqi Biotechnology Secukinumab Major Product Offerings
7.17.4 Sichuan Weiqi Biotechnology Secukinumab Sales and Revenue in Global (2017-2022)
7.17.5 Sichuan Weiqi Biotechnology Key News
7.18 Taizhou KEDE Chemical
7.18.1 Taizhou KEDE Chemical Corporate Summary
7.18.2 Taizhou KEDE Chemical Business Overview
7.18.3 Taizhou KEDE Chemical Secukinumab Major Product Offerings
7.18.4 Taizhou KEDE Chemical Secukinumab Sales and Revenue in Global (2017-2022)
7.18.5 Taizhou KEDE Chemical Key News
7.19 WeiShi Reagent
7.19.1 WeiShi Reagent Corporate Summary
7.19.2 WeiShi Reagent Business Overview
7.19.3 WeiShi Reagent Secukinumab Major Product Offerings
7.19.4 WeiShi Reagent Secukinumab Sales and Revenue in Global (2017-2022)
7.19.5 WeiShi Reagent Key News
7.20 Wuhan Dingxintong Pharmaceutical
7.20.1 Wuhan Dingxintong Pharmaceutical Corporate Summary
7.20.2 Wuhan Dingxintong Pharmaceutical Business Overview
7.20.3 Wuhan Dingxintong Pharmaceutical Secukinumab Major Product Offerings
7.20.4 Wuhan Dingxintong Pharmaceutical Secukinumab Sales and Revenue in Global (2017-2022)
7.20.5 Wuhan Dingxintong Pharmaceutical Key News
7.21 Wuhan Fortuna Chemical
7.21.1 Wuhan Fortuna Chemical Corporate Summary
7.21.2 Wuhan Fortuna Chemical Business Overview
7.21.3 Wuhan Fortuna Chemical Secukinumab Major Product Offerings
7.21.4 Wuhan Fortuna Chemical Secukinumab Sales and Revenue in Global (2017-2022)
7.21.5 Wuhan Fortuna Chemical Key News
7.22 Wuhan Topule Biopharmaceutical
7.22.1 Wuhan Topule Biopharmaceutical Corporate Summary
7.22.2 Wuhan Topule Biopharmaceutical Business Overview
7.22.3 Wuhan Topule Biopharmaceutical Secukinumab Major Product Offerings
7.22.4 Wuhan Topule Biopharmaceutical Secukinumab Sales and Revenue in Global (2017-2022)
7.22.5 Wuhan Topule Biopharmaceutical Key News
7.23 Wuhan Weisman Bioengineering
7.23.1 Wuhan Weisman Bioengineering Corporate Summary
7.23.2 Wuhan Weisman Bioengineering Business Overview
7.23.3 Wuhan Weisman Bioengineering Secukinumab Major Product Offerings
7.23.4 Wuhan Weisman Bioengineering Secukinumab Sales and Revenue in Global (2017-2022)
7.23.5 Wuhan Weisman Bioengineering Key News
7.24 Wuhan Yingnuo Pharmaceutical Technology
7.24.1 Wuhan Yingnuo Pharmaceutical Technology Corporate Summary
7.24.2 Wuhan Yingnuo Pharmaceutical Technology Business Overview
7.24.3 Wuhan Yingnuo Pharmaceutical Technology Secukinumab Major Product Offerings
7.24.4 Wuhan Yingnuo Pharmaceutical Technology Secukinumab Sales and Revenue in Global (2017-2022)
7.24.5 Wuhan Yingnuo Pharmaceutical Technology Key News
8 GLOBAL SECUKINUMAB PRODUCTION CAPACITY, ANALYSIS
8.1 Global Secukinumab Production Capacity, 2017-2028
8.2 Secukinumab Production Capacity of Key Manufacturers in Global Market
8.3 Global Secukinumab Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 SECUKINUMAB SUPPLY CHAIN ANALYSIS
10.1 Secukinumab Industry Value Chain
10.2 Secukinumab Upstream Market
10.3 Secukinumab Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Secukinumab Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Secukinumab in Global Market
Table 2. Top Secukinumab Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Secukinumab Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Secukinumab Revenue Share by Companies, 2017-2022
Table 5. Global Secukinumab Sales by Companies, (Kg), 2017-2022
Table 6. Global Secukinumab Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Secukinumab Price (2017-2022) & (US$/Kg)
Table 8. Global Manufacturers Secukinumab Product Type
Table 9. List of Global Tier 1 Secukinumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Secukinumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Secukinumab Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Secukinumab Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Secukinumab Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Secukinumab Sales (Kg), 2017-2022
Table 15. By Type - Global Secukinumab Sales (Kg), 2023-2028
Table 16. By Application – Global Secukinumab Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Secukinumab Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Secukinumab Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Secukinumab Sales (Kg), 2017-2022
Table 20. By Application - Global Secukinumab Sales (Kg), 2023-2028
Table 21. By Region – Global Secukinumab Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Secukinumab Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Secukinumab Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Secukinumab Sales (Kg), 2017-2022
Table 25. By Region - Global Secukinumab Sales (Kg), 2023-2028
Table 26. By Country - North America Secukinumab Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Secukinumab Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Secukinumab Sales, (Kg), 2017-2022
Table 29. By Country - North America Secukinumab Sales, (Kg), 2023-2028
Table 30. By Country - Europe Secukinumab Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Secukinumab Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Secukinumab Sales, (Kg), 2017-2022
Table 33. By Country - Europe Secukinumab Sales, (Kg), 2023-2028
Table 34. By Region - Asia Secukinumab Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Secukinumab Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Secukinumab Sales, (Kg), 2017-2022
Table 37. By Region - Asia Secukinumab Sales, (Kg), 2023-2028
Table 38. By Country - South America Secukinumab Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Secukinumab Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Secukinumab Sales, (Kg), 2017-2022
Table 41. By Country - South America Secukinumab Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Secukinumab Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Secukinumab Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Secukinumab Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Secukinumab Sales, (Kg), 2023-2028
Table 46. Carbosynth Corporate Summary
Table 47. Carbosynth Secukinumab Product Offerings
Table 48. Carbosynth Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 49. TargetMol Chemicals Corporate Summary
Table 50. TargetMol Chemicals Secukinumab Product Offerings
Table 51. TargetMol Chemicals Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 52. Changzhou Chenhong Biotechnology Corporate Summary
Table 53. Changzhou Chenhong Biotechnology Secukinumab Product Offerings
Table 54. Changzhou Chenhong Biotechnology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 55. DC Chemicals Corporate Summary
Table 56. DC Chemicals Secukinumab Product Offerings
Table 57. DC Chemicals Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 58. Huatesheng Biotechnology Corporate Summary
Table 59. Huatesheng Biotechnology Secukinumab Product Offerings
Table 60. Huatesheng Biotechnology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 61. Hubei Guangao Biotechnology Corporate Summary
Table 62. Hubei Guangao Biotechnology Secukinumab Product Offerings
Table 63. Hubei Guangao Biotechnology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 64. Hubei Kele Fine Chemical Corporate Summary
Table 65. Hubei Kele Fine Chemical Secukinumab Product Offerings
Table 66. Hubei Kele Fine Chemical Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 67. Hubei Widely Chemical Technology Corporate Summary
Table 68. Hubei Widely Chemical Technology Secukinumab Product Offerings
Table 69. Hubei Widely Chemical Technology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 70. Hubei Xingcheng Biotechnology Corporate Summary
Table 71. Hubei Xingcheng Biotechnology Secukinumab Product Offerings
Table 72. Hubei Xingcheng Biotechnology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 73. Hubei Zhongshan Medical Technology Corporate Summary
Table 74. Hubei Zhongshan Medical Technology Secukinumab Product Offerings
Table 75. Hubei Zhongshan Medical Technology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 76. Jiangxi Ruiweier Biotechnology Corporate Summary
Table 77. Jiangxi Ruiweier Biotechnology Secukinumab Product Offerings
Table 78. Jiangxi Ruiweier Biotechnology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 79. Nantong Hi-Future Biotechnology Corporate Summary
Table 80. Nantong Hi-Future Biotechnology Secukinumab Product Offerings
Table 81. Nantong Hi-Future Biotechnology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 82. Shanghai Biochempartner Corporate Summary
Table 83. Shanghai Biochempartner Secukinumab Product Offerings
Table 84. Shanghai Biochempartner Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 85. Shanghai Minkai Biotechnology Corporate Summary
Table 86. Shanghai Minkai Biotechnology Secukinumab Product Offerings
Table 87. Shanghai Minkai Biotechnology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 88. Shanghai Yifei Biotechnology Corporate Summary
Table 89. Shanghai Yifei Biotechnology Secukinumab Product Offerings
Table 90. Shanghai Yifei Biotechnology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 91. Shanghai Yu'ang Chemical Corporate Summary
Table 92. Shanghai Yu'ang Chemical Secukinumab Product Offerings
Table 93. Shanghai Yu'ang Chemical Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 94. Sichuan Weiqi Biotechnology Corporate Summary
Table 95. Sichuan Weiqi Biotechnology Secukinumab Product Offerings
Table 96. Sichuan Weiqi Biotechnology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 97. Taizhou KEDE Chemical Corporate Summary
Table 98. Taizhou KEDE Chemical Secukinumab Product Offerings
Table 99. Taizhou KEDE Chemical Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 100. WeiShi Reagent Corporate Summary
Table 101. WeiShi Reagent Secukinumab Product Offerings
Table 102. WeiShi Reagent Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 103. Wuhan Dingxintong Pharmaceutical Corporate Summary
Table 104. Wuhan Dingxintong Pharmaceutical Secukinumab Product Offerings
Table 105. Wuhan Dingxintong Pharmaceutical Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 106. Wuhan Fortuna Chemical Corporate Summary
Table 107. Wuhan Fortuna Chemical Secukinumab Product Offerings
Table 108. Wuhan Fortuna Chemical Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 109. Wuhan Topule Biopharmaceutical Corporate Summary
Table 110. Wuhan Topule Biopharmaceutical Secukinumab Product Offerings
Table 111. Wuhan Topule Biopharmaceutical Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 112. Wuhan Weisman Bioengineering Corporate Summary
Table 113. Wuhan Weisman Bioengineering Secukinumab Product Offerings
Table 114. Wuhan Weisman Bioengineering Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 115. Wuhan Yingnuo Pharmaceutical Technology Corporate Summary
Table 116. Wuhan Yingnuo Pharmaceutical Technology Secukinumab Product Offerings
Table 117. Wuhan Yingnuo Pharmaceutical Technology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 118. Secukinumab Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 119. Global Secukinumab Capacity Market Share of Key Manufacturers, 2020-2022
Table 120. Global Secukinumab Production by Region, 2017-2022 (Kg)
Table 121. Global Secukinumab Production by Region, 2023-2028 (Kg)
Table 122. Secukinumab Market Opportunities & Trends in Global Market
Table 123. Secukinumab Market Drivers in Global Market
Table 124. Secukinumab Market Restraints in Global Market
Table 125. Secukinumab Raw Materials
Table 126. Secukinumab Raw Materials Suppliers in Global Market
Table 127. Typical Secukinumab Downstream
Table 128. Secukinumab Downstream Clients in Global Market
Table 129. Secukinumab Distributors and Sales Agents in Global Market
Table 1. Key Players of Secukinumab in Global Market
Table 2. Top Secukinumab Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Secukinumab Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Secukinumab Revenue Share by Companies, 2017-2022
Table 5. Global Secukinumab Sales by Companies, (Kg), 2017-2022
Table 6. Global Secukinumab Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Secukinumab Price (2017-2022) & (US$/Kg)
Table 8. Global Manufacturers Secukinumab Product Type
Table 9. List of Global Tier 1 Secukinumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Secukinumab Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Secukinumab Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Secukinumab Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Secukinumab Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Secukinumab Sales (Kg), 2017-2022
Table 15. By Type - Global Secukinumab Sales (Kg), 2023-2028
Table 16. By Application – Global Secukinumab Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Secukinumab Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Secukinumab Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Secukinumab Sales (Kg), 2017-2022
Table 20. By Application - Global Secukinumab Sales (Kg), 2023-2028
Table 21. By Region – Global Secukinumab Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Secukinumab Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Secukinumab Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Secukinumab Sales (Kg), 2017-2022
Table 25. By Region - Global Secukinumab Sales (Kg), 2023-2028
Table 26. By Country - North America Secukinumab Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Secukinumab Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Secukinumab Sales, (Kg), 2017-2022
Table 29. By Country - North America Secukinumab Sales, (Kg), 2023-2028
Table 30. By Country - Europe Secukinumab Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Secukinumab Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Secukinumab Sales, (Kg), 2017-2022
Table 33. By Country - Europe Secukinumab Sales, (Kg), 2023-2028
Table 34. By Region - Asia Secukinumab Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Secukinumab Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Secukinumab Sales, (Kg), 2017-2022
Table 37. By Region - Asia Secukinumab Sales, (Kg), 2023-2028
Table 38. By Country - South America Secukinumab Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Secukinumab Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Secukinumab Sales, (Kg), 2017-2022
Table 41. By Country - South America Secukinumab Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Secukinumab Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Secukinumab Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Secukinumab Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Secukinumab Sales, (Kg), 2023-2028
Table 46. Carbosynth Corporate Summary
Table 47. Carbosynth Secukinumab Product Offerings
Table 48. Carbosynth Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 49. TargetMol Chemicals Corporate Summary
Table 50. TargetMol Chemicals Secukinumab Product Offerings
Table 51. TargetMol Chemicals Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 52. Changzhou Chenhong Biotechnology Corporate Summary
Table 53. Changzhou Chenhong Biotechnology Secukinumab Product Offerings
Table 54. Changzhou Chenhong Biotechnology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 55. DC Chemicals Corporate Summary
Table 56. DC Chemicals Secukinumab Product Offerings
Table 57. DC Chemicals Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 58. Huatesheng Biotechnology Corporate Summary
Table 59. Huatesheng Biotechnology Secukinumab Product Offerings
Table 60. Huatesheng Biotechnology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 61. Hubei Guangao Biotechnology Corporate Summary
Table 62. Hubei Guangao Biotechnology Secukinumab Product Offerings
Table 63. Hubei Guangao Biotechnology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 64. Hubei Kele Fine Chemical Corporate Summary
Table 65. Hubei Kele Fine Chemical Secukinumab Product Offerings
Table 66. Hubei Kele Fine Chemical Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 67. Hubei Widely Chemical Technology Corporate Summary
Table 68. Hubei Widely Chemical Technology Secukinumab Product Offerings
Table 69. Hubei Widely Chemical Technology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 70. Hubei Xingcheng Biotechnology Corporate Summary
Table 71. Hubei Xingcheng Biotechnology Secukinumab Product Offerings
Table 72. Hubei Xingcheng Biotechnology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 73. Hubei Zhongshan Medical Technology Corporate Summary
Table 74. Hubei Zhongshan Medical Technology Secukinumab Product Offerings
Table 75. Hubei Zhongshan Medical Technology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 76. Jiangxi Ruiweier Biotechnology Corporate Summary
Table 77. Jiangxi Ruiweier Biotechnology Secukinumab Product Offerings
Table 78. Jiangxi Ruiweier Biotechnology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 79. Nantong Hi-Future Biotechnology Corporate Summary
Table 80. Nantong Hi-Future Biotechnology Secukinumab Product Offerings
Table 81. Nantong Hi-Future Biotechnology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 82. Shanghai Biochempartner Corporate Summary
Table 83. Shanghai Biochempartner Secukinumab Product Offerings
Table 84. Shanghai Biochempartner Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 85. Shanghai Minkai Biotechnology Corporate Summary
Table 86. Shanghai Minkai Biotechnology Secukinumab Product Offerings
Table 87. Shanghai Minkai Biotechnology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 88. Shanghai Yifei Biotechnology Corporate Summary
Table 89. Shanghai Yifei Biotechnology Secukinumab Product Offerings
Table 90. Shanghai Yifei Biotechnology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 91. Shanghai Yu'ang Chemical Corporate Summary
Table 92. Shanghai Yu'ang Chemical Secukinumab Product Offerings
Table 93. Shanghai Yu'ang Chemical Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 94. Sichuan Weiqi Biotechnology Corporate Summary
Table 95. Sichuan Weiqi Biotechnology Secukinumab Product Offerings
Table 96. Sichuan Weiqi Biotechnology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 97. Taizhou KEDE Chemical Corporate Summary
Table 98. Taizhou KEDE Chemical Secukinumab Product Offerings
Table 99. Taizhou KEDE Chemical Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 100. WeiShi Reagent Corporate Summary
Table 101. WeiShi Reagent Secukinumab Product Offerings
Table 102. WeiShi Reagent Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 103. Wuhan Dingxintong Pharmaceutical Corporate Summary
Table 104. Wuhan Dingxintong Pharmaceutical Secukinumab Product Offerings
Table 105. Wuhan Dingxintong Pharmaceutical Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 106. Wuhan Fortuna Chemical Corporate Summary
Table 107. Wuhan Fortuna Chemical Secukinumab Product Offerings
Table 108. Wuhan Fortuna Chemical Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 109. Wuhan Topule Biopharmaceutical Corporate Summary
Table 110. Wuhan Topule Biopharmaceutical Secukinumab Product Offerings
Table 111. Wuhan Topule Biopharmaceutical Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 112. Wuhan Weisman Bioengineering Corporate Summary
Table 113. Wuhan Weisman Bioengineering Secukinumab Product Offerings
Table 114. Wuhan Weisman Bioengineering Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 115. Wuhan Yingnuo Pharmaceutical Technology Corporate Summary
Table 116. Wuhan Yingnuo Pharmaceutical Technology Secukinumab Product Offerings
Table 117. Wuhan Yingnuo Pharmaceutical Technology Secukinumab Sales (Kg), Revenue (US$, Mn) and Average Price (US$/Kg) (2017-2022)
Table 118. Secukinumab Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 119. Global Secukinumab Capacity Market Share of Key Manufacturers, 2020-2022
Table 120. Global Secukinumab Production by Region, 2017-2022 (Kg)
Table 121. Global Secukinumab Production by Region, 2023-2028 (Kg)
Table 122. Secukinumab Market Opportunities & Trends in Global Market
Table 123. Secukinumab Market Drivers in Global Market
Table 124. Secukinumab Market Restraints in Global Market
Table 125. Secukinumab Raw Materials
Table 126. Secukinumab Raw Materials Suppliers in Global Market
Table 127. Typical Secukinumab Downstream
Table 128. Secukinumab Downstream Clients in Global Market
Table 129. Secukinumab Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Secukinumab Segment by Type
Figure 2. Secukinumab Segment by Application
Figure 3. Global Secukinumab Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Secukinumab Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Secukinumab Revenue, 2017-2028 (US$, Mn)
Figure 7. Secukinumab Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Secukinumab Revenue in 2021
Figure 9. By Type - Global Secukinumab Sales Market Share, 2017-2028
Figure 10. By Type - Global Secukinumab Revenue Market Share, 2017-2028
Figure 11. By Type - Global Secukinumab Price (US$/Kg), 2017-2028
Figure 12. By Application - Global Secukinumab Sales Market Share, 2017-2028
Figure 13. By Application - Global Secukinumab Revenue Market Share, 2017-2028
Figure 14. By Application - Global Secukinumab Price (US$/Kg), 2017-2028
Figure 15. By Region - Global Secukinumab Sales Market Share, 2017-2028
Figure 16. By Region - Global Secukinumab Revenue Market Share, 2017-2028
Figure 17. By Country - North America Secukinumab Revenue Market Share, 2017-2028
Figure 18. By Country - North America Secukinumab Sales Market Share, 2017-2028
Figure 19. US Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Secukinumab Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Secukinumab Sales Market Share, 2017-2028
Figure 24. Germany Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 25. France Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Secukinumab Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Secukinumab Sales Market Share, 2017-2028
Figure 33. China Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 37. India Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Secukinumab Revenue Market Share, 2017-2028
Figure 39. By Country - South America Secukinumab Sales Market Share, 2017-2028
Figure 40. Brazil Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Secukinumab Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Secukinumab Sales Market Share, 2017-2028
Figure 44. Turkey Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 48. Global Secukinumab Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Secukinumab by Region, 2021 VS 2028
Figure 50. Secukinumab Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Secukinumab Segment by Type
Figure 2. Secukinumab Segment by Application
Figure 3. Global Secukinumab Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Secukinumab Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Secukinumab Revenue, 2017-2028 (US$, Mn)
Figure 7. Secukinumab Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Secukinumab Revenue in 2021
Figure 9. By Type - Global Secukinumab Sales Market Share, 2017-2028
Figure 10. By Type - Global Secukinumab Revenue Market Share, 2017-2028
Figure 11. By Type - Global Secukinumab Price (US$/Kg), 2017-2028
Figure 12. By Application - Global Secukinumab Sales Market Share, 2017-2028
Figure 13. By Application - Global Secukinumab Revenue Market Share, 2017-2028
Figure 14. By Application - Global Secukinumab Price (US$/Kg), 2017-2028
Figure 15. By Region - Global Secukinumab Sales Market Share, 2017-2028
Figure 16. By Region - Global Secukinumab Revenue Market Share, 2017-2028
Figure 17. By Country - North America Secukinumab Revenue Market Share, 2017-2028
Figure 18. By Country - North America Secukinumab Sales Market Share, 2017-2028
Figure 19. US Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Secukinumab Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Secukinumab Sales Market Share, 2017-2028
Figure 24. Germany Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 25. France Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Secukinumab Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Secukinumab Sales Market Share, 2017-2028
Figure 33. China Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 37. India Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Secukinumab Revenue Market Share, 2017-2028
Figure 39. By Country - South America Secukinumab Sales Market Share, 2017-2028
Figure 40. Brazil Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Secukinumab Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Secukinumab Sales Market Share, 2017-2028
Figure 44. Turkey Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Secukinumab Revenue, (US$, Mn), 2017-2028
Figure 48. Global Secukinumab Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Secukinumab by Region, 2021 VS 2028
Figure 50. Secukinumab Industry Value Chain
Figure 51. Marketing Channels
